Low-pro­file Be­yond­Spring files for $100M IPO to back can­cer work; Ery­tech ham­mered af­ter it pulls mar­ket­ing ap­pli­ca­tion

Be­yond­Spring Phar­ma­ceu­ti­cals, a low-pro­file biotech reg­is­tered in the Cay­man Is­lands with of­fices in New York and Chi­na, has filed for a $100 mil­lion IPO. The …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER